Blood Transfusion Diagnostics Market Size Worth US$ 8.7 Billion by 2033

At a Glance

Report Coverage

56 +

Countries

56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa

Year Assessment

Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)

9 +

Major Players

Major companies profiled including Grifols, S.A., F. Hoffmann-La Roche Ltd, Immucor, Inc., Bio-Rad Laboratories Inc., Abbott

400

Report Pages

Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets

What's Fueling Growth

Market Drivers

Rising prevalence of blood disorders
Growth in surgical procedures
Increasing demand for safe transfusions

Where Growth Opportunities Exist

Key Opportunities

Adoption in emerging healthcare markets
Innovation in rapid testing technologies
Integration with AI-based diagnostics

What Could Slow It Down

Market Restraints

High cost of advanced diagnostic system
Stringent regulatory requirement
Limited infrastructure in rural areas

Market Segmentation

Coverage by Segment

Product Type

Instruments[Blood Grouping Instruments

Others]

Kits and Reagents[Blood Grouping Kits and Reagents

Application (Blood Grouping [ABO Blood Grouping, Rh Blood Grouping, Red Blood Cell Antibody Screening, Extended Phenotyping, Cross Matching Tests], Disease Screening

End-user

Blood Banks

Blood Donation/Transfusion Centers

Others

Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Grifols, S.A.

F. Hoffmann-La Roche Ltd

Immucor, Inc.

Bio-Rad Laboratories Inc.

Abbott

Thermo Fisher Scientific Inc.

Ortho Clinical Diagnostics

DiaSorin S.p.A.

Quotient Limited

What's Inside

Report Scope & Deliverables

Market Size 2025	US$ 5.26 Billion
Market Size 2033	US$ 8.7 Billion
CAGR 2026–2033	6.49%
Segments	By Product Type (Instruments[Blood Grouping Instruments, Others], Kits and Reagents[Blood Grouping Kits and Reagents) \| By Application (Blood Grouping [ABO Blood Grouping, Rh Blood Grouping, Red Blood Cell Antibody Screening, Extended Phenotyping, Cross Matching Tests], Disease Screening \| By End-user (Blood Banks, Blood Donation/Transfusion Centers, Others)
Geographies	North America (US, Canada, Mexico) · Europe (Belgium, Austria, Finland, Denmark, Greece, Poland, Romania, Russia, Ukraine, Czech Republic, Slovakia, Bulgaria, Italy, Luxembourg, Germany, Switzerland, France, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom) · Asia-Pacific (Australia, China, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Bangladesh, New Zealand, Taiwan) · South and Central America (Brazil, Argentina, Peru, Chile, Colombia) · Middle East and Africa (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Turkiye, South Africa, Egypt, Algeria, Nigeria)
Deliverables	Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code	BMIPUB00032432
Lead Analyst	Krishna Sunthwal — Analyst, Research · View Profile

With Full Report Access

Gain actionable insights with 400 pages of in-depth Blood Transfusion Diagnostics Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.

View Report Summary Download Free Sample

Blood Transfusion Diagnostics Market Size & Forecast

Report Coverage

Market Drivers

Rising prevalence of blood disorders

Growth in surgical procedures

Increasing demand for safe transfusions

Key Opportunities

Adoption in emerging healthcare markets

Innovation in rapid testing technologies

Integration with AI-based diagnostics

Market Restraints

High cost of advanced diagnostic system

Stringent regulatory requirement

Limited infrastructure in rural areas